ACW 34.8% 6.2¢ actinogen medical limited

Ann: Market Update and ACW to Participate in BIO Digital, page-108

  1. 449 Posts.
    lightbulb Created with Sketch. 73
    Are you saying that safety of Xanamem with over two hundred patients taking the drug without any serious side effects and the efficacy of Xanahes trial plus the current studies eg, toxicology and target occupancy, maybe enough to progress to market? Just because no other drug has been developed for some yrs. the reason being. Am I on the same wavelength here.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.016(34.8%)
Mkt cap ! $166.3M
Open High Low Value Volume
4.5¢ 6.2¢ 4.4¢ $1.491M 28.50M

Buyers (Bids)

No. Vol. Price($)
1 50000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 100000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.